MedPath

Communication Skills Intervention to Promote Transition Into Survivorship

Active, not recruiting
Conditions
Hodgkin's Lymphoma
Diffuse Large B-cell Lymphoma
Registration Number
NCT01483664
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Brief Summary

The purpose of this study is to improve the communication skills of physicians who transition lymphoma cancer patients from the end of treatment to survivorship.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
314
Inclusion Criteria

Physicians:

  • who treat patients with DLBCL and HD as per self report

Patients of Physicians:

  • have a new diagnosis of Hodgkin's or Diffuse Large B-cell Lymphoma as per pathology report or physician assessment in medical record and/or clinical judgment of the treating physician treated with curative intent.

For part 1 - have scans indicating remission and completing planned chemotherapy and/or radiation therapy. The treating physician will determine that clinical remission has been achieved based on their best judgment.

For part 2 (longitudinal phase): - have new scans indicating remission and completing planned chemotherapy and/or radiation therapy. The treating physician will determine that clinical remission has been achieved based on their best judgment.

  • be at least 18 years old
  • speak English well enough, in the judgment of the consenting professional, to be able to understand all aspects of the study, provide informed consent, and be able to complete all study measures.
Read More
Exclusion Criteria

Physicians:

  • who do not have adequate patients in their clinical practice to meet the 8 patient enrollment requirement for patients with either DLBCL or HD as per self report

Patients of Physicians:

  • show evidence of cognitive impairment severe enough to preclude giving permission to the study staff, or completing the survey instruments of the study.
  • as per physician judgment, patient's prognosis and/or co-morbidities make them inappropriate for participation in a survivorship study.

For Part 2 ONLY (longitudinal phase):

  • those who consented to part 1, consult recording, of the study.
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
impact on patient outcomes of targeted physician communication skills training3 years
Secondary Outcome Measures
NameTimeMethod
impact of a targeted CST intervention on the physicians3 years

use of strategies, tasks and skills about transitioning lymphoma patients from the end of primary treatment to survivorship.

describe communication during doctor-patient visits during the patients' first three years of survivorship3 years

(MSKCC and MD Anderson baseline data only) The study team will look for qualitative themes to better understand the content of these conversations and the need for survivorship care planning. Half of these recordings were with MSKCC patients and physicians and half were with MD Anderson patients and physicians.

Trial Locations

Locations (9)

Maimonides Medical Center

🇺🇸

Brooklyn, New York, United States

Memorial Sloan Kettering at Basking Ridge

🇺🇸

Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Cancer Center at Commack

🇺🇸

Commack, New York, United States

Memorial Sloan Kettering Cancer Center

🇺🇸

New York, New York, United States

Memorial Sloan Kettering Cancer Center at Phelps

🇺🇸

Sleepy Hollow, New York, United States

Memorial Sloan Kettering Cancer Center at Mercy

🇺🇸

Rockville Centre, New York, United States

Md Anderson Cancer Center

🇺🇸

Houston, Texas, United States

Moffitt Cancer Center

🇺🇸

Tampa, Florida, United States

Tampa General Hospital

🇺🇸

Tampa, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath